| Date | Time | Source | |
| 04/02/2024 | 8:08AM | BW | Hologic to Announce Financial Results for the Second Quarter of Fiscal 2024 on Thursday, May 2, 2024
Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release its financial results for the second quarter of fiscal 2024 on Thursday, May 2, after the market closes. In conjunction with the release, management will host a conference call that day at 4:30 p.m. Eastern Time. Interested participants may... More...>> |
| 03/05/2024 | 8:10AM | BW | Newly Published Results Reveal a Significant Proportion of Early-Stage HR+ Breast Cancer Survivors May Be Over- or Undertreated Without Breast Cancer Index Genomic Testing
Results From a Large-Scale Prospective Study Investigating Long-Term Anti-Estrogen Therapy Recommendations Published in JNCCN — Journal of the National Comprehensive Cancer Network Hologic, Inc. (Nasdaq: HOLX) and its subsidiary, Biotheranostics, Inc., today announced newly published study results revealing that use... More...>> |
| 02/27/2024 | 8:00AM | BW | Hologic to Unveil Groundbreaking AI Research at ECR 2024
Global Leader in Women’s Health to Present Research and Educational Opportunities Focused on Improving Workflow and Efficiency Hologic, Inc. (Nasdaq: HOLX) continues to deliver on its commitment to advancing women’s health by unveiling new research in artificial intelligence (AI) and offering innovative educational... More...>> |
| 02/26/2024 | 4:15PM | BW | Hologic to Webcast Presentations at Upcoming Investor Conferences
Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at the following upcoming investor conferences: Raymond James' 45th Annual Institutional Investors Conference on Monday, March 4 at 8:40 a.m. Eastern Time (ET). Needham Virtual Healthcare Conference on Tuesday, April 9 at 11:45 a.m. ET. Each presentation... More...>> |
| 02/01/2024 | 5:35PM | BW | Hologic Announces First and Only FDA-Cleared Digital Cytology System – Genius™ Digital Diagnostics System
Through a Combination of Advanced Imaging and Novel Artificial Intelligence, Latest Diagnostic System for Cervical Cancer Screening Can Help More Accurately Detect Disease, Improve Workflow and Enhance Patient Care Hologic, Inc. (Nasdaq: HOLX) announced today that its new Genius™ Digital Diagnostics System with the Genius™... More...>> |
| 02/01/2024 | 4:01PM | BW | Hologic Announces Financial Results for First Quarter of Fiscal 2024
– Revenue of $1,013.1 Million, GAAP Diluted EPS of $1.03, and Non-GAAP Diluted EPS of $0.98; All Exceed Guidance – – Total Company Organic Revenue Growth Excluding COVID-19 of 5.2% in Constant Currency Against Four Fewer Selling Days Compared to the Prior Year Period – – Company Increases Full-Year Revenue and... More...>> |
| 01/16/2024 | 8:30AM | BW | Women's Health Remains in Crisis Worldwide Even as COVID-19 Pandemic Wanes
Third annual Hologic Global Women’s Health Index shows billions of women untested for life-threatening conditions, emotional health worsening and nearly 1 billion women living with physical pain. Taiwan tops rankings of women’s health by country/territory; U.S. falls to number 30. The world faces an emergency in women’s... More...>> |
| 01/11/2024 | 8:08AM | BW | Hologic Launches ‘Better Is Possible’ Health Awareness Campaign for Women
Leader in Women’s Health Encourages Women to Stop Suffering in Silence and Talk to Their Doctor About Disruptive Period Symptoms Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health, today announced its new uterine health education and awareness campaign Better is Possible™. Launching in New York, Los... More...>> |
| 01/07/2024 | 4:00PM | BW | Hologic Announces Preliminary Revenue Results for First Quarter of Fiscal 2024
– Revenue of $1,013.1 Million Exceeds Guidance – – 5.2% Organic Constant Currency Revenue Growth ex. COVID-19, also Exceeding Guidance – Hologic, Inc. (Nasdaq: HOLX) announced today preliminary revenue results for its first fiscal quarter ended December 30, 2023. The Company expects to report total revenues of... More...>> |
| 01/04/2024 | 8:33AM | BW | Hologic to Announce Financial Results for the First Quarter of Fiscal 2024 on Thursday, February 1, 2024
Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release its financial results for the first quarter of fiscal 2024 on Thursday, February 1, after the market closes. In conjunction with the release, management will host a conference call that day at 4:30 p.m. Eastern Time. Interested participants... More...>> |
| 01/02/2024 | 8:08AM | BW | Hologic to Webcast Presentation at the 42nd Annual J.P. Morgan Healthcare Conference
Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024, at 1:30 p.m. Pacific Time. The presentation and Q&A session will be webcast live and may be accessed through a link on the Investors section of Hologic’s website... More...>> |
| 11/30/2023 | 6:00AM | BW | KKR, Hologic and Ajax Health Create New Platform to Accelerate Medical Device Innovation
Platform Will Focus on Technologies to Detect Lung Cancer, the Leading Cause of Cancer Deaths KKR, a leading global investment firm, today announced a new platform established with investments from KKR and Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health and medical technology innovator. The new platform... More...>> |
| 11/24/2023 | 8:05AM | BW | Hologic to Showcase Developments in Next-Generation AI Solutions at RSNA 2023
Leader in Women’s Health Will Highlight New Imaging Solutions That Aid in Cancer Detection and Radiologist Workflow Hologic, Inc. (Nasdaq: HOLX) will showcase several recent developments in next-generation AI solutions at the 109th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA... More...>> |
| 11/21/2023 | 8:15AM | BW | Hologic to Webcast Presentation at the 6th Annual Evercore ISI HealthCONx Conference
Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at the 6th Annual Evercore ISI HealthCONx Conference on Tuesday, November 28, 2023, at 2:10 p.m. Eastern Time. The fire-side chat presentation will be webcast live and may be accessed through a link on the investors section of Hologic’s website... More...>> |
| 11/09/2023 | 4:01PM | BW | Hologic Announces Financial Results for Fourth Quarter of Fiscal 2023
– Revenue of $945.3 Million, GAAP Diluted EPS of $0.37, and Non-GAAP Diluted EPS of $0.89 – – Total Company Organic Revenue Growth excluding COVID-19 of 16.7% in constant currency – – Expect Broad Based Strong Performance in Fiscal 2024 – Hologic, Inc. (Nasdaq: HOLX) announced today the Company’s financial... More...>> |
| 10/10/2023 | 8:30AM | BW | Hologic Announces Innovative Collaboration with AAGL and Inovus Medical to Optimize OB-GYN Training for Minimally Invasive Surgeries
Partnership to Include Integration of Hologic Products, Specifically Designed for Gynecologic Care, into Hands-On Skills Education for OB-GYN Residents Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health, today announced an innovative new partnership with the American Association of Gynecologic Laparoscopists... More...>> |
| 10/05/2023 | 8:00AM | BW | Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2023 on Thursday, November 9, 2023
Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release its financial results for the fourth quarter of fiscal 2023 on Thursday, November 9, after the market closes. In conjunction with the release, management will host a conference call that day at 4:30 p.m. Eastern Time. Interested participants... More...>> |
| 09/29/2023 | 8:00AM | BW | Hologic to Expand Outreach During Breast Cancer Awareness Month
Launches Global Partnership With Know Your Lemons, Will Ring Nasdaq Opening Bell for 17th Time Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health, today announced a series of activities promoting the importance of breast cancer screenings throughout Breast Cancer Awareness Month, including a global partnership... More...>> |
| 09/22/2023 | 8:00AM | BW | Nanaz Mohtashami Elected to Hologic Board of Directors
Hologic, Inc. (Nasdaq: HOLX) announced today that Nanaz Mohtashami has been elected to the Company’s Board of Directors, effective September 20, 2023. Ms. Mohtashami was also appointed to the Compensation Committee and the Nominating and Corporate Governance Committee effective September 20, 2023. This press release... More...>> |
| 09/21/2023 | 8:30AM | BW | Hologic and Bayer Announce International Partnership to Deliver Comprehensive Contrast-Enhanced Mammography Package to Breast Imaging Facilities
Partnership Includes Education and Training to Increase Clinician Confidence in the Use of CEM, an Emerging Breast Imaging Modality Hologic Inc. (Nasdaq: HOLX) and Bayer today announced an international partnership to deliver contrast-enhanced mammography (CEM) solutions to improve the detection of breast cancer for women... More...>> |